BioSpace News Archive

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2019.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the first quarter ended March 31, 2019

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three months ended March 31, 2019 and provides an update on its business progress.

Tetraphase Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2019, provided an overview of recent achievements, and highlighted key milestones for 2019.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced financial results for the quarter ended March 31, 2019

Enrollment is Ongoing in Phase 2b Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C; Topline Data Readout Anticipated in 2H 2019

Danaher Corporation announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Rainer Blair, will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 15, 2019 at 8:00 a.m. PT.

Advanced Energy Sales of $4.4 million in Q1, up 66% year-over-year

Conference call and webcast today at 4:30 p.m. ET

Webcast Today at 4:30 pm Eastern Time